Literature DB >> 12771287

Ophthalmoplegia in Powassan encephalitis.

Simmons Lessell1, T Edward Collins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12771287     DOI： 10.1212/01.wnl.0000064167.16083.02

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Tick-Borne Flaviviruses, with a Focus on Powassan Virus.

Authors:  Gábor Kemenesi; Krisztián Bányai
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

Review 2.  Powassan Virus Encephalitis.

Authors:  Anne Piantadosi; Isaac H Solomon
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

Review 3.  Emerging Tick-Borne Diseases.

Authors:  Susan Madison-Antenucci; Laura D Kramer; Linda L Gebhardt; Elizabeth Kauffman
Journal:  Clin Microbiol Rev       Date:  2020-01-02       Impact factor: 26.132

Review 4.  Non-lyme tick-borne diseases: a neurological perspective.

Authors:  Navid Seraji-Bozorgzad; Alexandros C Tselis
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 6.030

Review 5.  Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America.

Authors:  Meghan E Hermance; Saravanan Thangamani
Journal:  Vector Borne Zoonotic Dis       Date:  2017-05-12       Impact factor: 2.133

Review 6.  Powassan virus infection: case series and literature review from a single institution.

Authors:  Mihir Raval; Mayank Singhal; Dubert Guerrero; Augusto Alonto
Journal:  BMC Res Notes       Date:  2012-10-30

7.  Powassan meningoencephalitis, New York, New York, USA.

Authors:  Simon Sung; Alysse G Wurcel; Susan Whittier; Karen Kulas; Laura D Kramer; Robin Flam; James Kirkland Roberts; Simon Tsiouris
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

Review 8.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.